YHYintong Huang

Yintong Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yintong Huang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Beisi Lin

    Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China

    1 shared publication
  • Daizhi Yang

    Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China

    1 shared publication
  • Longyi Zeng

    Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Ruofan Wang

    Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China

    1 shared publication
  • Shuo Lin

    Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China

    1 shared publication
  • Wei Jiang

    Department of General Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510530, China

    1 shared publication

Latest Publications

  • Open Access

    Effects of Intensive Insulin Therapy Within One Week on Glycemic Control and β-Cell Function in Patients with T2DM

    by Wei Jiang, Xubin Yang, Beisi Lin, Zhigu Liu, Xuanrong Chen, Shuo Lin, Daizhi Yang, Yintong Huang, Ruofan Wang, Wen Xu, et al.

    Objective: To evaluate the impact of intensive insulin therapy (IIT) within 1 week on glycemic control and β-cell function indices in patients with type 2 diabetes mellitus (T2DM). Methods: This retrospective study included 726 patients with T2DM who underwent continuous subcutaneous insulin infusion within 1 week. Patients were divided into three groups based on disease duration: short (≤1 year), medium (>1 and p < 0.01 for both). HOMA-β, 30 min insulinogenic index, 30 min disposition index, and insulin secretion sensitivity index-2 markedly improved from baseline [37.69 (41.03) VS. 32.40 (46.06), 3.16 (3.97) VS. 2.12 (3.51), 336.85 (397.05) VS. 188.93 (263.45), and 185.92 (122.89) VS. 120.81 (90.12), respectively] (p < 0.01 for all). Insulin sensitivity, measured by HOMA-IR and Matsuda index, significantly improved (p < 0.01 for both). Significantly greater improvements in glycemic control and β-cell function measures were observed in patients with a shorter diabetes duration. Age, duration of diabetes, BMI, HbA1c, duration of IIT, and time in range were significantly associated with improvements in β-cell function indices. Conclusions: IIT within 1 week was associated with improved glycemic control and β-cell function indices in T2DM patients, with the most pronounced benefits observed in those with a shorter disease duration.